These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25102300)

  • 21. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.
    Hovland S; Muller S; Skomedal H; Mints M; Bergström J; Wallin KL; Karlsen F; Johansson B; Andersson S
    Int J Oncol; 2010 Jun; 36(6):1533-9. PubMed ID: 20428778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
    J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.
    Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X
    J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical performance of human papillomavirus E6, E7 mRNA flow cytometric assay compared to human papillomavirus DNA typing.
    Kottaridi C; Tsiodras S; Spathis A; Chranioti A; Pappas A; Kassanos D; Panayiotides I; Karakitsos P
    Anal Quant Cytol Histol; 2011 Dec; 33(6):305-10. PubMed ID: 22590807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic accuracy of E6 & 7 mRNA detection as a primary screening test for the detection of severe cervical lesions.
    Stathopoulou V; Koliopoulos G; Zygouris D; Pappas A; Spathis A; Karakitsos P; Kassanos D; Chrelias C
    J BUON; 2014; 19(2):490-6. PubMed ID: 24965411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry.
    Narimatsu R; Patterson BK
    Am J Clin Pathol; 2005 May; 123(5):716-23. PubMed ID: 15981811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
    Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
    J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.
    Jeantet D; Schwarzmann F; Tromp J; Melchers WJ; van der Wurff AA; Oosterlaken T; Jacobs M; Troesch A
    J Clin Virol; 2009 Jul; 45 Suppl 1():S29-37. PubMed ID: 19651366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
    Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
    Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey.
    Tüney İ; Altay A; Ergünay K; Önder SÇ; Usubütün A; Salman MC; Bozdayi G; Karabulut E; Badur OS; Yüce K; Pinar A
    Turk J Med Sci; 2017 Feb; 47(1):194-200. PubMed ID: 28263489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of the RNA-based HPV test in the diagnostics of cervical epithelial changes].
    Doganov A; Kostova P; Boyanova M; Velcheva D; Tchoncheva V; Mainhard K; Zlatkov V
    Akush Ginekol (Sofiia); 2012; 51(3):22-4. PubMed ID: 23236661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV detection methods and genotyping techniques in screening for cervical cancer.
    Eide ML; Debaque H
    Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol.
    Padalko E; Van Renterghem L; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Weyers S; Praet M
    J Med Virol; 2013 Jul; 85(7):1242-9. PubMed ID: 23918543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.